High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer

Etoposide-Cisplatin Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in Patients with Extensive Disease Combined with Small Cell Lung Cancer

(2014) Jie Zhang et al.   Asian Pacific Journal of Cancer Prevention

Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System

(2013) B. J. Laird et al.   CLINICAL CANCER RESEARCH

Combined SCLC Clinical and Pathologic Characteristics

(2012) Shahab Babakoohi et al.   Clinical Lung Cancer

Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer

(2011) Soojung Hong et al.   YONSEI MEDICAL JOURNAL

The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer

(2010) G. Kasymjanova et al.   Current Oncology

The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970–2004

(2009) Yien Ning S Wong et al.   BMC CANCER

Inflaming metastasis

(2009) Alberto Mantovani   NATURE

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

(2008) L. A. Hefler et al.   CLINICAL CANCER RESEARCH

Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer

(2008) Jin Gu Lee et al.   LUNG CANCER

An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer

(2008) Donald C. McMillan   PROCEEDINGS OF THE NUTRITION SOCIETY